Skip to main content
Year archive

Extrawell Pharmaceutical Holdings Limited — 2023 filings

All 39 regulatory filings released by Extrawell Pharmaceutical Holdings Limited (858) in 2023, sourced directly from the official regulator.

39 Filings
2023 Period
2023 filings (39)
Filing Released Lang
Interim Report 2023/24
Interim / Quarterly Report H1 2024
2023-12-18 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
Regulatory Filings
2023-12-01 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Interim / Quarterly Report H1 2024
2023-11-29 English
DATE OF BOARD MEETING
Regulatory Filings
2023-11-14 English
PROFIT WARNING
Capital/Financing Update
2023-11-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2023
Share Issue/Capital Change
2023-11-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2023
Regulatory Filings
2023-10-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
Regulatory Filings
2023-09-04 English
Memorandum of Association and Bye-Laws
Governance Information
2023-08-25 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 25 AUGUST 2023
Declaration of Voting Results & Voting Rights Announcements
2023-08-25 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-01 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-07-28 English
FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 25 AUGUST 2023 AT 11:00 A.M.
Proxy Solicitation & Information Statement
2023-07-28 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE NEW SHARES AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS AND ADOPTION OF NEW BYE-LAWS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-07-28 English
Annual Report 2023
Regulatory Filings
2023-07-28 English
PROPOSED AMENDMENTS TO THE BYE-LAWS
Governance Information
2023-07-27 English
COMPLETION OF MAJOR TRANSACTION CONCERNING THE PROPOSED THIRD AMENDMENTS TO THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS ISSUED BY INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED
Capital/Financing Update
2023-07-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-04 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2023
Annual Report FY 2023
2023-06-29 English
EXTENSION OF LONG STOP DATE IN RESPECT OF PROPOSED THIRD AMENDMENTS TO THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS
Capital/Financing Update
2023-06-29 English
POLL RESULTS OF SPECIAL GENERAL MEETING HELD ON 28 JUNE 2023
Declaration of Voting Results & Voting Rights Announcements
2023-06-28 English
COMPLETION OF DISCLOSEABLE TRANSACTION IN RELATION TO A SHARE BUY-BACK TRANSACTION OF A NON-WHOLLY OWNED SUBSIDIARY
Transaction in Own Shares
2023-06-19 English
PROFIT WARNING
Regulatory Filings
2023-06-16 English
DATE OF BOARD MEETING
Regulatory Filings
2023-06-15 English
Documents on Display
Regulatory Filings
2023-06-12 English
NOTICE OF SPECIAL GENERAL MEETING
Regulatory Filings
2023-06-09 English
FORM OF PROXY FOR SPECIAL GENERAL MEETING TO BE HELD ON WEDNESDAY, 28 JUNE 2023 AT 3:00 P.M.
Proxy Solicitation & Information Statement
2023-06-09 English
MAJOR TRANSACTION CONCERNING THE PROPOSED THIRD AMENDMENTS TO THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS ISSUED BY INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED AND NOTICE OF SPECIAL GENERAL MEETIN
Proxy Solicitation & Information Statement
2023-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-02 English
MAJOR TRANSACTION - PROPOSED THIRD AMENDMENTS TO THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS
Capital/Financing Update
2023-04-28 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2023-04-14 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGES IN COMPOSITION OF BOARD COMMITTEES
Board/Management Information
2023-04-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-03 English
DISCLOSEABLE TRANSACTION IN RELATION TO A SHARE BUY-BACK TRANSACTION OF A NON-WHOLLY OWNED SUBSIDIARY
Transaction in Own Shares
2023-03-31 English
EXTENSION OF TIME FOR APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Board/Management Information
2023-03-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-03 English